Clinical trial
Antibody Persistence in 11 to 13-year-old Children Previously Vaccinated at 6 Years Old With Either REVAXIS or DT Polio, and Immune Response to a Booster Dose of TETRAVAC-ACELLULAIRE
NCT01546909 is registered in ClinicalTrials.gov with Sanofi Pasteur, a Sanofi Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Antibody Persistence in 11 to 13-year-old Children Previously Vaccinated at 6 Years Old With Either REVAXIS or DT Polio, and Immune Response to a Booster Dose of TETRAVAC-ACELLULAIRE
- Lead sponsor
- Sanofi Pasteur, a Sanofi Company
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 29, 2012
- Completion date
- December 31, 2012
- Enrollment
- 278 (actual)
- Sites
- 45
Conditions
As the registry lists them; a condition with its own page is linked.